ENTITY

Aurinia Pharmaceuticals (AUPH US)

Analysis

Health Care • Canada

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of immunosuppressive therapeutics.

Refresh

No events found

We’ll display events we find for Aurinia Pharmaceuticals here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00